Cargando…
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another lig...
Autores principales: | Ishida, Tasuku, Ciulli, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013866/ https://www.ncbi.nlm.nih.gov/pubmed/33143537 http://dx.doi.org/10.1177/2472555220965528 |
Ejemplares similares
-
E3 ligase ligand optimization of Clinical PROTACs
por: Jiang, Hanrui, et al.
Publicado: (2023) -
Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
por: Diehl, Claudia J., et al.
Publicado: (2022) -
Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs
por: Girardini, Miriam, et al.
Publicado: (2019) -
E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points
por: Bricelj, Aleša, et al.
Publicado: (2021) -
What are karrikins and how were they ‘discovered’ by plants?
por: Flematti, Gavin R., et al.
Publicado: (2015)